Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
Alzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment...
Main Authors: | Jutamas Jiaranaikulwanitch, Hataichanok Pandith, Sarin Tadtong, Phanit Thammarat, Supat Jiranusornkul, Nattapong Chauthong, Supitcha Nilkosol, Opa Vajragupta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/6/1562 |
Similar Items
-
From BACE1 Inhibitor to Multifunctionality of Tryptoline and Tryptamine Triazole Derivatives for Alzheimer’s Disease
by: Jutamas Jiaranaikulwanitch, et al.
Published: (2012-07-01) -
Potential Anti-Alzheimer Agents from Guanidinyl Tryptophan Derivatives with Activities of Membrane Adhesion and Conformational Transition Inhibitions
by: Pathomwat Wongrattanakamon, et al.
Published: (2021-08-01) -
Cosmeceutical Potentials of <i>Equisetum debile</i> Roxb. ex Vaucher Extracts
by: Phanit Thammarat, et al.
Published: (2023-01-01) -
Lead discovery of a guanidinyl tryptophan derivative on amyloid cascade inhibition
by: Suwanttananuruk Piyapan, et al.
Published: (2020-06-01) -
Activity of Cytosolic Ascorbate Peroxidase (APX) from <i>Panicum virgatum</i> against Ascorbate and Phenylpropanoids
by: Bixia Zhang, et al.
Published: (2023-01-01)